Albumedix Expands Production Capacity at its Commercial-Scale Recombinant Human Albumin Manufacturing Plant and Opens New Research Facilities
Albumedix Ltd. ( Albumedix ), a recognized global leader in recombinant human albumin specializing in the enablement of advanced therapies, announces the completed expansion of the company’s commercial-scale manufacturing facility, alongside with the establishment of a new Technology Centre equipped with state-of-the-art laboratories at its UK-based campus in Nottingham.
Albumedix Expands Production Capacity at rHA Manufacturing Plant and Opens New Research Facilities
Play
Capacity expansion at the company’s cGMP manufacturing plant in Nottingham, UK will enable Albumedix to support its next wave of clients from pre-clinical development through to market